A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan

[1] Liu GG(2012)The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan Value Health 15 S65-S71

[2] DiBonaventura M(2015)A review of the burden of hepatitis C virus infection in China Japan South Korea and Taiwan Hepatol Int 9 378-390

[3] Yuan Y(2014)Global epidemiology and genotype distribution of the hepatitis C virus infection J Hepatol 61 S45-S57

[4] Bennett H(2016)Past, present, and future of viral hepatitis C in Japan Euroasian J Hepatogastroenterol 6 49-51

[5] Waser N(2009)Epidemiology of hepatocellular carcinoma in Japan J Gastroenterol 44 102-107

[6] Johnston K(2018)Cost of illness of hepatocellular carcinoma in Japan: a time trend and future projections PLoS One 13 e0199188-50

[7] Gower E(2015)Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan Liver Cancer 4 39-195

[8] Estes C(2011)Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale Intervirology 54 185-1840

[9] Blach S(2018)Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C J Med Virol 90 1834-70

[10] Razavi-Shearer K(2014)JSH guidelines for the management of hepatitis C virus infection: a 2014 update for genotype 1 Hepatol Res 44 59-1451

[1] Liu GG(2012)The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan Value Health 15 S65-S71

[2] DiBonaventura M(2015)A review of the burden of hepatitis C virus infection in China Japan South Korea and Taiwan Hepatol Int 9 378-390

[3] Yuan Y(2014)Global epidemiology and genotype distribution of the hepatitis C virus infection J Hepatol 61 S45-S57

[4] Bennett H(2016)Past, present, and future of viral hepatitis C in Japan Euroasian J Hepatogastroenterol 6 49-51

[5] Waser N(2009)Epidemiology of hepatocellular carcinoma in Japan J Gastroenterol 44 102-107

[6] Johnston K(2018)Cost of illness of hepatocellular carcinoma in Japan: a time trend and future projections PLoS One 13 e0199188-50

[7] Gower E(2015)Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan Liver Cancer 4 39-195

[8] Estes C(2011)Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale Intervirology 54 185-1840

[9] Blach S(2018)Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C J Med Virol 90 1834-70

[10] Razavi-Shearer K(2014)JSH guidelines for the management of hepatitis C virus infection: a 2014 update for genotype 1 Hepatol Res 44 59-1451